Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...
Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...
The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...
The Southeast STD/HIV Prevention and Training Center is a regional collaboration of nationally respected experts experts in sexual and reproductive health. For over three decades, the Southeast ...